| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3832778 | F | Antimalarial activity: Asexual Blood Stage Plasmodium falciparum 3D7 IC50 (uM) | Plasmodium falciparum | 125 | organism-based format | MMV Pathogen Box | ||
| 2. | ALA3832781 | F | Antimalarial activity: Liver Stage Plasmodium berghei sporozoite Luciferase assay: inhibition at 10 uM (%) | Plasmodium berghei | 120 | organism-based format | MMV Pathogen Box | ||
| 3. | ALA3832785 | F | AntiTrypanosoma cruzi activity IC50 (uM) | Trypanosoma cruzi | 65 | organism-based format | MMV Pathogen Box | ||
| 4. | ALA3832786 | F | AntiTrypanosoma brucei activity T. b. brucei IC50 (uM) | Trypanosoma brucei | 64 | organism-based format | MMV Pathogen Box | ||
| 5. | ALA3832787 | F | AntiTrypanosoma brucei activity T. b. rhodesiense IC50 (uM) | Trypanosoma brucei | 62 | organism-based format | MMV Pathogen Box | ||
| 6. | ALA3832789 | F | AntiLeishmania activity L. infantum (macrophages) IC50 (uM) | Leishmania infantum | 65 | organism-based format | MMV Pathogen Box | ||
| 7. | ALA3832842 | F | MRC5 CC50 (uM) Cytotoxicity | 77 | cell-based format | MMV Pathogen Box | |||
| 8. | ALA3832843 | F | PMM CC50 (uM) Cytotoxicity | 65 | cell-based format | MMV Pathogen Box | |||
| 9. | ALA3987222 | B | Compound was evaluated for the inhibition of human FECH at 10uM | Homo sapiens | 400 | single protein format | MMV Pathogen Box | ||
| 10. | ALA3987223 | B | Compound was evaluated for the inhibition of human HMBS at 100uM | Homo sapiens | 400 | assay format | MMV Pathogen Box | ||
| 11. | ALA4296184 | F | Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600) | Staphylococcus aureus | 4,588 | organism-based format | CO-ADD antimicrobial screening data | ||
| 12. | ALA4296185 | F | Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600) | Escherichia coli | 4,585 | organism-based format | CO-ADD antimicrobial screening data | ||
| 13. | ALA4296186 | F | Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600) | Klebsiella pneumoniae | 6,160 | organism-based format | CO-ADD antimicrobial screening data | ||
| 14. | ALA4296187 | F | Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600) | Pseudomonas aeruginosa | 24,161 | organism-based format | CO-ADD antimicrobial screening data | ||
| 15. | ALA4296188 | F | Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600 | Acinetobacter baumannii | 22,588 | organism-based format | CO-ADD antimicrobial screening data | ||
| 16. | ALA4296189 | F | Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630 | Candida albicans | 6,134 | organism-based format | CO-ADD antimicrobial screening data | ||
| 17. | ALA4296190 | F | Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570) | Cryptococcus neoformans | 6,133 | organism-based format | CO-ADD antimicrobial screening data | ||
| 18. | ALA4296191 | F | Cytotoxicity against HEK293 cells (CO-ADD:MA_007); CC50 by cell viability assay in DMEM (10% FBS) media using TC plates, by Resazurin F(560/590) | Homo sapiens | 899 | cell-based format | CO-ADD antimicrobial screening data | ||
| 19. | ALA4296784 | F | Haemolysis of human Red Blood Cells (CO-ADD:HA_150); HC10, by OD(450) | Homo sapiens | 490 | cell-based format | CO-ADD antimicrobial screening data | ||
| 20. | ALA4513102 | F | Growth inhibiting activity of Naegleria gruberi in vitro | Naegleria gruberi | 399 | organism-based format | MMV Pathogen Box |
The page will load shortly, Thanks for your patience!